NasoClenz by Silicon Valley Innovations, Inc.

NasoClenz by

Drug Labeling and Warnings

NasoClenz by is a Otc medication manufactured, distributed, or labeled by Silicon Valley Innovations, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

NASOCLENZ- benzalkonium chloride 0.13% gel 
Silicon Valley Innovations, Inc.

----------

NasoClenz Cleansing Kit Drug Facts

Active Ingredient

Benzalkonium chloride (0.13%)

Uses

  • Helps reduce bacteria that can cause skin infections

  • Antiseptic preparation to decrease bacteria on skin

Warnings

For external use only, do not ingest.

Do Not Use

  • If you are allergic to any of the ingredients
  • In or near the eyes
  • On children under 2 years of age

Ask a doctor before use if you have

  • Deep or puncture wounds
  • Serious burns

Stop use and ask a doctor if

  • Irritation, swelling, pain or other symptoms develop

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  1. Apply gel to tip of Cleansing Wand
  2. Insert tip with gel into nostril, rotating it in each direction several times
  3. Wipe any excess gel from nose with a tissue

  • Use every 4-8 hours as needed
  • Children under age 12 use with adult supervision

Other Information

Protect from excessive heat (temperatures about 104°F/40°C)

Inactive Ingredients - 81900-013

Carbomer, Diethylene Glycol Monoethyl Ether, Glycerin, Propylene Glycol, Triethanolamine, Water

Inactive Ingredients - 81900-014

Carbomer, Diethylene Glycol Monoethyl Ether, Glycerin, Peppermint Oil, Propylene Glycol, Triethanolamine, Water

Questions?

Call 1-844-4MY-NASO

OR (1-844-469-6276)

M-F 9am to 5pm PST

NasoClenz.com

Principal Display Panel - 81900-013

Drug Facts

Principal Display Panel - 81900-014

Drug Facts

NASOCLENZ 
benzalkonium chloride 0.13% gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 81900-014
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y) BENZALKONIUM CHLORIDE1.19 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
GLYCERIN (UNII: PDC6A3C0OX)  
DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)  
TROLAMINE (UNII: 9O3K93S3TK)  
CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: F68VH75CJC)  
PEPPERMINT OIL (UNII: AV092KU4JH)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 81900-014-031 in 1 BOX09/25/202301/23/2026
112 mL in 1 TUBE; Type 1: Convenience Kit of Co-Package
2NDC: 81900-014-042 in 1 BOX09/25/202301/23/2026
21 in 1 POUCH
21 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
3NDC: 81900-014-054 in 1 BOX09/25/202301/23/2026
31 in 1 POUCH
31 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
4NDC: 81900-014-061 in 1 BOX02/16/202401/23/2026
45 mL in 1 TUBE; Type 1: Convenience Kit of Co-Package
5NDC: 81900-014-081 in 1 BOX05/26/202501/23/2026
512 mL in 1 TUBE; Type 7: Separate Products Requiring Cross Labeling
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)09/25/202301/23/2026
NASOCLENZ 
benzalkonium chloride 0.13% gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 81900-013
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y) BENZALKONIUM CHLORIDE1.19 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
TROLAMINE (UNII: 9O3K93S3TK)  
CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: F68VH75CJC)  
DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)  
GLYCERIN (UNII: PDC6A3C0OX)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 81900-013-031 in 1 BOX07/15/202201/23/2026
112 mL in 1 TUBE; Type 1: Convenience Kit of Co-Package
2NDC: 81900-013-042 in 1 BOX07/15/202201/23/2026
21 in 1 POUCH
21 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
3NDC: 81900-013-054 in 1 BOX07/15/202201/23/2026
31 in 1 POUCH
31 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
4NDC: 81900-013-6060 in 1 BOX11/15/202201/23/2026
41 in 1 POUCH
41 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
5NDC: 81900-013-0140 in 1 BOX11/01/202101/23/2026
51 in 1 POUCH
51 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
6NDC: 81900-013-028 in 1 BOX11/01/202101/23/2026
61 in 1 POUCH
61 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
7NDC: 81900-013-061 in 1 BOX02/16/202401/23/2026
75 mL in 1 TUBE; Type 1: Convenience Kit of Co-Package
8NDC: 81900-013-081 in 1 BOX05/26/202501/23/2026
812 mL in 1 TUBE; Type 7: Separate Products Requiring Cross Labeling
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)11/01/202101/23/2026
Labeler - Silicon Valley Innovations, Inc. (118048729)
Registrant - Silicon Valley Innovations, Inc. (118048729)
Establishment
NameAddressID/FEIBusiness Operations
Silicon Valley Innovations, Inc.118048729label(81900-013, 81900-014) , pack(81900-013, 81900-014)

Revised: 2/2026
Document Id: 4b482304-ea19-a471-e063-6294a90a7f24
Set id: e3274271-ebd7-26c9-e053-2a95a90ad0f8
Version: 7
Effective Time: 20260220
 

Trademark Results [NasoClenz]

Mark Image

Registration | Serial
Company
Trademark
Application Date
NASOCLENZ
NASOCLENZ
90552171 not registered Live/Pending
Silicon Valley Innovations, Inc.
2021-03-01
© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.